1 |
Gulnaz A, Chang J, Maeng H, Shin K, Lee K, Chae Y. A mechanism-based understanding of altered drug pharmacokinetics by gut microbiota. J Pharm Investig 2022. [DOI: 10.1007/s40005-022-00600-z] [Reference Citation Analysis]
|
2 |
Fan M, Shan M, Lan X, Fang X, Song D, Luo H, Wu D. Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer. Front Pharmacol 2022;13:1033017. [DOI: 10.3389/fphar.2022.1033017] [Reference Citation Analysis]
|
3 |
Wu Y, Cai Y, Ma L, Li F, Zhang M, Wang Y, Zheng F, Pi Z, Yue H. Identification and chemical profiling of anti-alcoholic liver disease biomarkers of ginseng Huang jiu using UPLC-Q-Orbitrap-HRMS and network pharmacology-based analyses. Front Nutr 2022;9:978122. [PMID: 36034901 DOI: 10.3389/fnut.2022.978122] [Reference Citation Analysis]
|
4 |
St-Laurent T, Hammami R. The Untapped Potential of Ginsenosides and American Ginseng Berry in Promoting Mental Health via the Gut-Brain Axis. Nutrients 2022;14:2523. [PMID: 35745252 DOI: 10.3390/nu14122523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Chen Z, Zhang Z, Liu J, Qi H, Li J, Chen J, Huang Q, Liu Q, Mi J, Li X. Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation. Front Cell Infect Microbiol 2022;12:853981. [DOI: 10.3389/fcimb.2022.853981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|